Table 2

Optimal cut points of IHC markers used to predict OS*

Marker*Optimal cut point selectedr-CHOP
e-CHOP
c-CHOP
HR (95% CI)Log-rank PHR (95% CI)Log-rank PHR (95% CI)Log-rank P
BCL2 ≤ 75% vs > 75% 1.4 (0.9, 2.2) .09 1.7 (1.4, 2.1) < .0001 1.6 (1.1, 2.3) .02 
BCL6 No staining vs staining 1.1 (0.5, 2.7) .76 1.7 (1.3, 2.3) .0003 2.9 (1.7, 5.0) < .0001 
CD5 ≤ 75% vs > 75% 2.4 (1.3, 4.3) .003 1.6 (1.2, 2.2) .004 1.0 (0.6, 1.9) .9 
CD10 Negative vs positive 1.1 (0.8, 1.7) .56 1.2 (0.9, 1.5) .17 1.4 (1.0, 2.0) .06 
HLA-DR Negative vs positive 1.3 (0.7, 2.4) .36 1.6 (1.2, 2.1) .001 1.3 (0.8, 1.9) .33 
Ki67 ≤ 75% vs > 75% 1.8 (1.1, 2.9) .02 0.8 (0.7, 1.0) .11 1.0 (0.6, 1.5) .86 
MUM1 ≤ 75% vs > 75% 1.4 (0.8, 2.3) .22 1.3 (1.0, 1.7) .03 1.5 (1.0, 2.4) .06 
Marker*Optimal cut point selectedr-CHOP
e-CHOP
c-CHOP
HR (95% CI)Log-rank PHR (95% CI)Log-rank PHR (95% CI)Log-rank P
BCL2 ≤ 75% vs > 75% 1.4 (0.9, 2.2) .09 1.7 (1.4, 2.1) < .0001 1.6 (1.1, 2.3) .02 
BCL6 No staining vs staining 1.1 (0.5, 2.7) .76 1.7 (1.3, 2.3) .0003 2.9 (1.7, 5.0) < .0001 
CD5 ≤ 75% vs > 75% 2.4 (1.3, 4.3) .003 1.6 (1.2, 2.2) .004 1.0 (0.6, 1.9) .9 
CD10 Negative vs positive 1.1 (0.8, 1.7) .56 1.2 (0.9, 1.5) .17 1.4 (1.0, 2.0) .06 
HLA-DR Negative vs positive 1.3 (0.7, 2.4) .36 1.6 (1.2, 2.1) .001 1.3 (0.8, 1.9) .33 
Ki67 ≤ 75% vs > 75% 1.8 (1.1, 2.9) .02 0.8 (0.7, 1.0) .11 1.0 (0.6, 1.5) .86 
MUM1 ≤ 75% vs > 75% 1.4 (0.8, 2.3) .22 1.3 (1.0, 1.7) .03 1.5 (1.0, 2.4) .06 
*

The number of the 1514 patients scored for BCL2, BCL6, CD5, CD10, HLA-dr, Ki67, MUM1, are 1306, 985, 1366, 1344, 1377, 1138, 1249, respectively

When optimal cut points were not determined using the r-CHOP series, the e-CHOP cut points are presented. Results obtained from applying the cut points to all cohorts are shown.

Reference groups: ≤ 75% staining for BCL2, CD5, MUM1, and Ki67; any staining for BCL6; positive for CD10 and HLA-DR.

or Create an Account

Close Modal
Close Modal